Edwards Lifesciences Corp.
(NYSE : EW)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
DHRDanaher Corp. -0.34%265.520.7%$613.38m
TMOThermo Fisher Scientific, Inc. 0.14%521.001.0%$590.41m
MDTMedtronic Plc -0.99%82.730.6%$545.15m
ABTAbbott Laboratories -0.32%100.750.8%$528.64m
ISRGIntuitive Surgical, Inc. -0.29%190.520.8%$345.03m
SYKStryker Corp. -0.91%206.981.3%$289.15m
BSXBoston Scientific Corp. -1.02%38.901.0%$254.76m
BDXBecton, Dickinson & Co. -1.32%234.061.0%$240.65m
EWEdwards Lifesciences Corp. 0.71%84.770.4%$238.81m
DXCMDexCom, Inc. -0.37%80.661.9%$189.15m
AAgilent Technologies, Inc. -0.73%123.481.7%$183.21m
IDXXIDEXX Laboratories, Inc. 2.49%334.203.9%$173.71m
ALGNAlign Technology, Inc. 2.06%222.436.4%$172.49m
BAXBaxter International, Inc. 0.11%55.431.8%$166.03m
NEOGNeogen Corp. -1.20%14.790.5%$151.45m

Company Profile

Edwards Lifesciences Corp. engages in the patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into three areas: Transcatheter Heart Valves, Surgical Structural Heart, and Critical Care. The Transcatheter Heart Valves portfolio includes technologies designed to treat heart valve disease using catheter-based approaches as opposed to open surgical techniques. The Surgical Structural Heart portfolio includes tissue heart valves and heart valve repair products for the surgical replacement or repair of a patient's heart valve. The Critical Care portfolio products through hemodynamic monitoring systems measures a patient's heart function and fluid status in surgical and intensive care settings. The company was founded by Miles Lowell Edwards in 1958 and is headquartered in Irvine, CA.